Your browser doesn't support javascript.
loading
Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.
Olafsdottir, Elinborg J; Borg, Ake; Jensen, Maj-Britt; Gerdes, Anne-Marie; Johansson, Anna L V; Barkardottir, Rosa B; Johannsson, Oskar T; Ejlertsen, Bent; Sønderstrup, Ida Marie Heeholm; Hovig, Eivind; Lænkholm, Anne-Vibeke; Hansen, Thomas van Overeem; Olafsdottir, Gudridur H; Rossing, Maria; Jonasson, Jon G; Sigurdsson, Stefan; Loman, Niklas; Nilsson, Martin P; Narod, Steven A; Tryggvadottir, Laufey.
Afiliação
  • Olafsdottir EJ; Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.
  • Borg A; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Jensen MB; Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Johansson ALV; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Barkardottir RB; Laboratory of Cell Biology, Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
  • Johannsson OT; Faculty of Medicine, BMC, Laeknagardur, University of Iceland, Reykjavik, Iceland.
  • Ejlertsen B; Department of Oncology, Landspitali University Hospital, Reykjavik, Iceland.
  • Sønderstrup IMH; Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Hovig E; Department of Clinical Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Lænkholm AV; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Hansen TVO; Department of Tumor Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Olafsdottir GH; Department of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark.
  • Rossing M; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Jonasson JG; Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.
  • Sigurdsson S; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Loman N; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Nilsson MP; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
  • Narod SA; Cancer Research Laboratory, BMC, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Tryggvadottir L; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Br J Cancer ; 123(11): 1608-1615, 2020 11.
Article em En | MEDLINE | ID: mdl-32939053
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article